Literature DB >> 17097557

The p27Kip1 tumor suppressor gene: Still a suspect or proven guilty?

Kornelia Polyak1.   

Abstract

The p27Kip1 cyclin-dependent kinase inhibitor is considered to be a tumor suppressor even though somatic mutations in p27Kip1 are only rarely detected in human tumors. On the other hand, overwhelming evidence indicates that its hemizygous or posttranscriptional loss plays an important role in tumorigenesis. Based on these data, p27Kip1 was classified as a haploinsufficient tumor suppressor whose protein level has to be fine-tuned for optimal function. However, a recent study links germline mutations in p27Kip1 to multiple endocrine neoplasia syndrome in rats and humans, thus establishing p27Kip1 as a bona fide tumor suppressor gene.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17097557     DOI: 10.1016/j.ccr.2006.10.015

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  3 in total

1.  Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function.

Authors:  Daniel Lindberg; Göran Akerström; Gunnar Westin
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

2.  C-Reactive Protein Is a Poor Marker of Baseline Inflammation in Prostate Cancer and Response to Radiotherapy or Androgen Ablation.

Authors:  Garrett L Jensen; Jason Naziri; Kendall P Hammonds; Sameer G Jhavar; Gregory Swanson
Journal:  Cureus       Date:  2021-11-16

Review 3.  p27, The Cell Cycle and Alzheimer´s Disease.

Authors:  Ana García-Osta; Jinya Dong; María Jesús Moreno-Aliaga; Maria Javier Ramirez
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.